ATBECHDEDKESFRGBGRITLILUNLSEMCPTIESILTLVFIRO....AL..............................*JDIM360 Ver 2.15 (14 Jul 2008) - 2999001/02008071101ATBECHDEDKESFIFRGBGRIEITLUMCNLPTSEThe file contains technical information submitted after the application was filed and not included in this specification0882134CORRECTED EUROPEAN PATENT SPECIFICATIONB8B120090902W172deBibliographieenBibliographyfrBibliographieEP97906764.2199702201998091120050223enenen60462719960221US2009090220093619981209199850200904222009172008071120090902200936C12N 15/86 20060101AFI19970930BHEP A61K 48/00 20060101ALI19970930BHEP C12N 7/04 20060101ALI19970930BHEP C12N 15/19 20060101ALI19970930BHEP C07K 14/16 20060101ALI19970930BHEP C12N 5/10 20060101ALI19970930BHEP C12N 5/06 20060101ALI19970930BHEP A61K 51/12 20060101ALI19970930BHEP deVERFAHREN UND ZUSAMMENSETZUNGEN ZUR GENETISCH SCHÜTZENDEN UND THERAPEUTISCHEN IMMUNISIERUNGenMETHODS AND COMPOSITIONS FOR PROTECTIVE AND THERAPEUTIC GENETIC IMMUNIZATIONfrPROCEDES ET COMPOSITIONS POUR L'IMMUNISATION GENETIQUE PROTECTRICE ET THERAPEUTIQUEWO-A-92/20356WO-A-96/06177WO-A1-94/24267GENE THERAPY OF CANCER : 2ND EUROPEAN CONFERENCE, LONDON, UK, SEPTEMBER 7-8 1995 HEEMSKERK, MHM et al.: "Melanoma-specific CTL, generated in viro using dendritic cells expressing melanoma associated antigens". Page A13 XP000675471JOURNAL OF IMMUNOLOGY, vol. 154, May 1995, BALTIMORE US, pages 4685-4692, XP000676343 WANG, M. ET AL.: "Active immunotherapy of cancer with a nonreplicating recombinant Fowlpox Virus encoding a model tumor-associated antigen"TRANSPLANTATION, vol. 59, no. 4, 27 February 1995, pages 544-551, XP000675701 THOMSON, A.W. ET AL.: "In vitro propagation and homing of liver-derived dendritic cell progenitors to lymphoid tissues of allogeneic recipients"AIDS RESEARCH AND HUMAN RETROVIRUSES, vol. 9, no. SUPPL. 01, 1 October 1993, page S33 XP000560222 KLEIN M ET AL: "DEVELOPMENT OF A CROSS-NEUTRALIZING HIV-1 PSEUDOVIRION-BASED VACCINE"JOURNAL OF VIROLOGY, vol. 69, no. 1, 1 January 1995, pages 376-386, XP000560257 WISKERCHEN M ET AL: "HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 INTEGRASE: EFFECTS OF MUTATIONS ON VIRAL ABILITY TO INTEGRATE, DIRECT VIRAL GENE EXPRESSION FROM UNINTEGRATED VIRAL DNA TEMPLATES, AND SUSTAIN VIRAL PROPAGATION IN PRIMARY CELLS"LISZIEWICZ J. ET AL.: 'induction of potent human immunodeficiency virus type 1 specific T-cell restricted immunity by genetically-modified dendritic cells' J. VIROL. vol. 75, no. 16, 2001, pages 7621 - 7628LISZIEWICZ J. ET AL.: 'DermaVir: a novel topical vaccine for HIV/AIDS' J. INVEST DERMATOL. 2004, pages 1 - 10LISZIEWICZ J. ET AL.: "Control of viral rebound through therapeutic immunisation with DermaVir" AIDS, vol. 19, 2005, pages 35-43,J. LISZIEWICZ ET AL.: 'Control of HIV despite the discontinuation of antiretroviral therapy' NEW ENGLAND J. MED vol. 340, no. 21, 1999, pages 1683 - 1684LISZIEWICZ, Juliannac/o Genetic Immunity Kft. Berlini str. 47-49H-1045 BudapestHULORI, Francoc/o Genetic Immunity Kft. Berlini str. 47-49H-1045 BudapestHUGenetic Immunity kft.08861330HMJ 03301 EPBerlini str. 47-49Budapest 1045HUJones, Helen M.M.00057931Gill Jennings & Every LLP Broadgate House 7 Eldon StreetLondon EC2M 7LHGBATBECHDEDKESFIFRGBGRIEITLILUMCNLPTSEAL19980904LT19980904LV19980904RO19980904SI19980904US199700293319970220enWO19970311191997082819973719981209199850